Chemours (CC)
(Delayed Data from NYSE)
$19.65 USD
-0.11 (-0.56%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $19.87 +0.22 (1.12%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.65 USD
-0.11 (-0.56%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $19.87 +0.22 (1.12%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth B Momentum D VGM
Zacks News
Here's Why You Should Invest In Chemours (CC) Stock Now
by Zacks Equity Research
Chemours (CC) is gaining from higher volumes on the back of strong demand, its cost and pricing actions and strong execution.
Chemours (CC) Evaluates Capacity Investments for Hydrogen Economy
by Zacks Equity Research
Chemours' (CC) higher ionomers capacity would support demand growth within water electrolysis and fuel cell technology.
Is Chemours (CC) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Chemours (CC) and Gerdau (GGB) have performed compared to their sector so far this year.
Chemours (CC) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Chemours (CC) Declares New Process for APA Grade Viton Production
by Zacks Equity Research
Chemours (CC) now has the potential to produce the complete Viton fluoroelastomers portfolio using a non-fluorinated surfactant.
Chemours (CC) Stock Pops 44% in 3 Months: What's Driving It?
by Zacks Equity Research
Chemours (CC) is benefiting from strong end-market demand and its cost-reduction and pricing actions.
Zacks Industry Outlook Highlights Dow, Albemarle, Huntsman and The Chemours
by Zacks Equity Research
Dow, Albemarle, Huntsman and The Chemours have been highlighted in this Industry Outlook article.
4 Stocks to Buy From the Promising Diversified Chemical Industry
by Anindya Barman
An upswing in demand in major end markets should enable the Zacks Chemicals Diversified industry to thrive. DOW, ALB, HUN and CC are set to gain from favorable industry fundamentals and strategic actions to counter cost inflation.
Is Chemours (CC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include Imperial Oil, CF Industry Holdings, The Chemours, Medifast, and APA
by Zacks Equity Research
Imperial Oil, CF Industry Holdings, The Chemours, Medifast, and APA are part of Screen of the Week article.
5 High Earnings Yield Value Picks Amid Market Jitters
by Rimmi Singhi
Value investing should be one of the most effective investment approaches now. IMO, CF, CC, MED and APA are some high earnings yield value stocks to tide over market mayhem.
The Zacks Analyst Blog Highlights Penske Automotive Group, Griffon, Louisiana-Pacific, The Chemours, and Avnet
by Zacks Equity Research
Penske Automotive Group, Griffon, Louisiana-Pacific, The Chemours, and Avnet are part of Zacks top Analyst Blog.
Is Chemours (CC) a Great Stock for Value Investors?
by Zacks Equity Research
Is Chemours (CC) a great pick from the value investor's perspective right now? Read on to know more.
5 Must-Buy Mid Cap Winners of Past Month With More Upside
by Nalak Das
We have narrowed our search to five mid-cap stocks that have popped double-digit in the past month, with more upside. These are: LPX, GFF, PAG, CC and AVT.
Should You Buy Chemours (CC) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Are Basic Materials Stocks Lagging Carpenter Technology (CRS) This Year?
by Zacks Equity Research
Here is how Carpenter Technology (CRS) and Chemours (CC) have performed compared to their sector so far this year.
Chemours (CC) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
Chemours (CC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Chemours (CC) Earnings and Revenues Top Estimates in Q1
by Zacks Equity Research
Chemours (CC) gains on strong volumes and higher prices amid headwinds from raw material cost inflation and logistics challenges in Q1.
Chemours (CC) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 58.70% and 14.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Scotts Miracle-Gro (SMG) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
ScottsMiracle-Gro's (SMG) Q2 performance is likely to have benefited from strength in the U.S. Consumer segment and cost savings.
Andersons (ANDE) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Andersons's (ANDE) Q1 performance is likely to reflect benefits from strong demand and high commodity and fertilizer prices.
TimkenSteel (TMST) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
TimkenSteel (TMST) is expected to have benefited, in the first quarter, from higher demand in industrial and energy end markets.
DuPont (DD) Gears Up for Q1 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from strong demand and productivity actions. However, higher raw material and logistics costs are expected to have hurt its Q1 results.
Why Chemours (CC) Might Surprise This Earnings Season
by Zacks Equity Research
Chemours (CC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Will Higher Prices Benefit Nutrien (NTR) in Q1 Earnings?
by Zacks Equity Research
Higher prices aided by strong demand and tight supply are likely to have driven Nutrien's (NTR) sales and margins in the first quarter.